• SENSEX 71,909.70
    -570.59 (--0.79%)
  • BANKNIFTY 54,450.75
    -182.30 (--0.33%)
  • ICICI Bank
    1,305.50 1,187.55(%)
  • NSE
    1,735.10 1,735.10(%)
  • Moneyview
    62.00 62.00(%)
  • HDFC Bank
    721.45 1,020.35(%)
  • Reliance Industries
    1,161.00 1,161.00(%)
  • Bharti Airtel
    1,726.05 1,726.05(%)
  • Kotak Mah. Bank
    435.55 452.98(%)
  • Infosys
    1,035.00 1,727.85(%)
  • Eternal
    309.80 212.55(%)
  • Molbio Diagnosti
    1,569.80 1,686.50(%)
  • SBI
    945.55 857.30(%)
  • Hero Motors
    167.80 167.80(%)
  • PB Fintech.
    965.00 965.00(%)
  • M & M
    2,812.60 2,812.60(%)
  • T R I L
    298.70 501.25(%)
  • Cupid
    314.40 314.40(%)
  • Ather Energy
    1,372.85 566.00(%)
  • Bank of Baroda
    234.00 325.55(%)
  • A-One Steels
    469.45 469.45(%)
  • Maruti Suzuki
    11,304.30 11,304.30(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Vivo Bio Tech Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 3920.0
  • ISIN : INE380K01017
17.13 0 (0.41%)
  • As on 01 Oct 2026 (EOD)

  • Today’s Low

    16.50

  • Today’s High

    17.99

  • Open

    16.90

  • Perv Close

    17.06

  • 52W Low

    15.51

  • 52W High

    20.94

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    38.01

  • Div & Yield %

    0.00

  • Book Value(₹)

    41.28

  • Debt-Equity Ratio

    0.41

  • AGM Date

    01-Oct-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    1.27

  • Mar.Cap (₹Cr.)

    38.01

  • RONW (%)

    4.76

  • ROCE (%)

    9.88

Score Board

  • Equity (₹ in Cr.)

    22.19

  • BV (₹)

    41.30

  • Sales( ₹ in Cr.)

    52.57

  • NP (in Cr.)

    -2.19

  • NP Var(%)

    -216.0

  • Div%

    0.0

  • CPS (₹)

    3.80

  • EPS (₹)

    -1.00

  • Traded Value (₹ in Lakhs)

    38.30

  • 52 Week High

    20.94

  • 52 Week Low

    15.51

  • Price BSE

    17.0

  • Price NSE

    17.00

  • Market Capital( in Cr.)

    38.30

  • P/C Ratio

    4.50

  • P/E Ratio

    -17.20

  • Price Vs.BV

    -1.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 52.57 46.67 44.88 51.62 51.39 51.78
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 52.57 46.67 44.88 51.62 51.39 51.78
Other Income 0.44 4.80 0.04 0.04 0.09 0.08
Stock Adjustments 0.36 -0.98 0.80 -1.84 -3.47 2.70
Total Income 53.37 50.49 45.72 49.82 48.01 54.56
EXPENDITURE :            
Raw Materials 8.49 4.81 4.65 4.93 7.97 9.91
Power and Fuel Cost 3.20 3.28 3.93 4.27 3.56 5.78
Employee Cost 15.95 11.86 10.13 13.15 9.42 8.57
Other Manufacturing Expenses 2.02 2.07 1.69 2.56 3.03 1.42
Selling and Administration Expenses 1.98 2.82 4.00 3.05 7.76 11.02
Miscellaneous Expenses 0.60 0.00 0.02 0.00 0.10 -0.02
Employee Benefit Expenses 15.95 11.86 10.13 13.15 9.42 8.57
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 32.25 24.85 24.43 27.96 31.83 36.67
Operating Profit 21.12 25.65 21.30 21.86 16.18 17.88
Interest 5.91 7.55 7.95 7.99 4.27 3.67
Gross Profit 15.21 18.10 13.35 13.87 11.91 14.21
Depreciation 10.63 9.02 9.29 9.27 7.44 5.59
Profit Before Tax 4.58 9.08 4.06 4.60 4.47 8.62
Current Tax 0.81 2.08 1.68 1.03 0.76 1.36
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 5.71 -0.57 -0.14 0.94 1.51 1.58
Reported Net Profit -1.94 7.57 2.52 2.63 2.20 5.68
Extraordinary Items 0.26 5.67 0.00 0.00 0.00 0.00
Adjusted Net Profit -2.20 1.90 2.52 2.63 2.20 5.68
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 29.08 21.51 18.98 16.35 14.15 8.46
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 27.14 29.08 21.51 18.98 16.35 14.15
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -0.87 4.41 1.69 1.77 1.54 4.24
Earnings Per Share(Adj)-Unit Curr -0.87 4.41 1.69 1.77 1.54 4.24
Book Value 41.28 41.32 36.50 34.81 32.57 30.64
Book Value(Adj)-Unit Curr 41.28 41.32 36.50 34.81 32.57 30.64

Shareholding Pattern

  • Promoter Group

    30.62%

  • Public Share Holding

    69.38%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 4,745,000 21.38 4,745,000 5
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,049,500 9.24 2,049,500 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 6,794,500 30.62 6,794,500 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 6,448,730 29.06 6,440,890 49
Clearing Members 100 0.00 100 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 421,218 1.90 421,218 97
Foreign Non Institution Other 1,310,538 5.91 10,538 2
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,358,829 10.63 2,303,829 47
Individuals holding nominal share capital up to Rs. 1 lakh 4,856,713 21.89 4,606,586 21,018
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 15,396,128 69.38 13,783,161 21,214
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 22,190,628 100.00 20,577,661 21,224

Company Background

Vivo Bio Tech LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Vivo Bio Tech Ltd
  • BSE Code : 3920.0
  • ISIN : INE380K01017

  • Incorporation Year

    1987

  • Registered Office

    Survey #349/A Pregnapur Vlge
    , Gajel,
    Telangana-502311

  • Telephone

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    Bhavish Vijayvargiya

  • Auditor

    P Murali & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Aarthi Consultants Pvt Ltd
    1-2-285,
    Domalguda,J B Apartments
    Mumbai - Hyderabad - 500 029

Vivo Bio Tech Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Abbott India 26,832.10 7,217.19 6,929.05 35.31 43.78
Astrazeneca Phar 6,030.45 2,304.07 2,275.58 88.88 27.86
Glaxosmi. Pharma 2,774.50 3,932.76 3,790.20 44.32 58.17
Novartis India 1,967.85 393.10 354.33 49.69 15.94
Cipla 1,346.85 20,102.60 18,979.95 35.40 13.88
Bliss GVS Pharma 684.20 773.53 729.81 63.59 12.51
Fermenta Biotec. 551.35 474.15 450.25 25.74 18.77
Amrutanjan Healt 513.80 520.13 502.55 27.52 24.16
Guj. Themis Bio. 382.35 168.25 165.82 102.23 18.05
Ambalal Sarabhai 37.92 19.52 3.94 70.22 6.77